Amgen Inc. is betting big on the future of American biotechnology with an announcement of plans to invest more than $600 million in a cutting-edge science and innovation center at its Thousand Oaks headquarters. The facility represents the latest move in the pharmaceutical giant's aggressive domestic expansion strategy, which has seen the company pour billions […]
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.

Signup for news and special announcements!
You have successfully joined our subscriber list.
Global Mutual's fledgling Botsford Global Partners platform has closed on Acacia Capital's...
ByThe RegistryNovember 11, 2026A private investor with a condominium track record paid $3.88 million for...
ByThe RegistryNovember 11, 2026Douglas Emmett lifted office occupancy to 76.7 percent in the third quarter...
ByThe RegistryNovember 11, 2026San Diego lab vacancy just hit a new cycle high and Los...
ByThe RegistryNovember 11, 2026Error: Contact form not found.